Veterinary Vaccine Adjuvants Market Size (2024 - 2029)

Veterinary Vaccine Adjuvants Market Analysis

The veterinary vaccine adjuvant market is expected to register a CAGR of 6.4% over the forecast period.

The COVID-19 pandemic impacted the veterinary vaccine adjuvants market. It highlighted the adaptability and response of veterinary healthcare to an emerging infectious disease and its role in maintaining animal health and protecting human public health. The increasing adoption of companion animals has increased the demand for vaccines, thus positively impacting the market. For instance, according to the People's Dispensary for Sick Animals (PDSA) PAW report published in June 2021, 2.0 million people in the United Kingdom owned pets between March 2020 and May 2021. Similarly, as per the report published by Nederlandse Voedingsindustrie Gezelschapsdieren(NVG) in 2021, around 8.0% of Dutch households started keeping a pet during the pandemic, which was around 6.4% during 2020, and another 7.0% intended to keep a pet. Out of the 8.0% of households that took a pet into their home during the pandemic, 47.0% of the people chose a dog and 27.0% chose a cat. Thus, the market witnessed positive growth during the pandemic, and it is expected to maintain an upward trend over the forecast period.

The rising use of adjuvants in the vaccine, the increasing livestock population and their associated diseases, and the high incidence of various diseases are the major drivers for the market. The high incidence of various diseases is one of the key factors propelling the market's growth. For instance, as per the NCBI study published in September 2021, anemia is the most common condition in sow herds, especially during gestation. The condition occurs despite iron supplementation in feed and has been associated with an increased stillbirth rate. Similarly, as per the report published by the CDC in September 2021, Bovine Spongiform Encephalopathy (BSE) is one of the most prevalent chronic diseases among cattle in Canada. The report stated that the true prevalence of Bovine Spongiform Encephalopathy (BSE) in Canada was around 90.0%, which is higher than the prevalence of BSE in the United States (3.0-8.0 cases per million Canada and around 0.167 cases per million in the United States). As per the report published by the Government of Canada in April 2022, various avian species, turkeys, ducks/chickens, geese, and peafowls were infected by avian influenza in March 2022. The disease is spreading rapidly among all livestock species, owing to which the government is planning to adopt necessary steps to control the spread. Thus, such a high prevalence of diseases may propel the demand for veterinary vaccines adjuvants, which is expected to surge the market's growth over the forecast period.

The increasing livestock population and associated diseases are also boosting the market's growth. For instance, according to the report published by Statistics Canada in May 2022, farms in Canada reported 12.6 million total cattle in 2021, up from 12.5 million in the previous year. The percentage increase in milk cows, steers, and beef cows offset declines in heifers for slaughter, heifers for dairy herd replacement, heifers for beef herd replacement, and bulls. According to the research study published in the Infection Ecology & Epidemiology in September 2021, one of the most dangerous zoonotic diseases in the world is salmonellosis. Salmonella prevalence in animals and risk factors for increased transmission of salmonella spp. from animals to people were evident. Thus, owing to the increasing livestock population and associated diseases across the world, the market is expected to grow considerably over the forecast period.

However, high toxicity and side effects of adjuvants may hinder the market's growth over the forecast period.

Veterinary Vaccine Adjuvants Industry Segmentation

As per the scope of the report, vaccine adjuvants are substances that help to enhance the immune response of the vaccine. The adjuvants can be broadly classified into two types, the first one is vaccine delivery systems and the second one is immunostimulatory adjuvants. 

The veterinary vaccine adjuvants market is segmented by type (alum and calcium salts, oil emulsion adjuvants, liposomes and archaeosomes, nanoparticles and microparticles, and other types), route of administration (oral, subcutaneous, intramuscular, and other routes of administration), animal type (livestock and companion animals), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions, globally. The report offers the value (in USD million) for the above segments.